Transforming the sensitivity, viability and profitability of lateral flow testing

Our revolutionary technology can make existing lateral flow tests 10 million times more sensitive

Our Techology

eAMP (enhanced Amplification) can be simply incorporated into existing manufacturing processes, and is easily customised for the chosen target illness. This means that:

Existing lateral flow tests become simpler to implement, more marketable and profitable
Vast numbers of illnesses can now be detected early and affordably using lateral flow tests
Lateral flow could replace more complex and expensive tests like ELISA and PCR

Our Vision 

To transform healthcare with our new generation of lateral flow tests


The research behind our discovery


A new generation of lateral flow applications


How we can support you

Our Team

The SwiftDx team